訊息原文

1 人回報3 個月前
Simon, Simon, Simon, Simon, Simon, Simon, Simon.

現有回應

目前尚無回應

增加新回應

  • 撰寫回應
  • 使用相關回應 11
  • 搜尋

你可能也會對這些類似文章有興趣

  • 黎智英助手Mark Simon被踢爆委託撰寫拜登兒子醜聞 深夜辭職 https://www.hk01.com/article/542723?utm_source=01appshare&utm_medi
    1 人回報1 則回應6 年前
  • 降血糖最好的食物是佛手瓜藤,也就龍鬚菜 Simon的血糖160-170多,用什麼方法保括秋葵水都試過,沒有効.四個月前開始吃佛手瓜籐,才吃3天血糖降低到110 到現在保持隔幾天吃,血糖保持在100一103飯前.有一個台中的朋友6年前吃了三個月龍鬚菜,到現在一直保持血糖沒有再高。
    1 人回報2 則回應6 年前
  • 轉傳: 民進黨四年前以及今年兩次壓錯寶。 [終場一定要算總帳的] 國際政治情勢詭譎多變,如果你無法左右逢源,最好就是乖乖閉嘴,不要輕易表態。 結果這個民進黨政府不但大膽的單押獨門,還放任底下的側翼組織與廢青(1450/817),對拜登極盡嘲諷之能事,而且在川普陣營的暗助下,與黎智英的香港蘋果集團、反拜登的「法輪功」側翼媒體同流,幹下很多「不能說的秘密」。 為什麼蔡英文政府前兩要突然召開什麽國安高層會議? 當然,在美國代表蔡英文政府的蕭美琴,眼看風向不對奉命求見拜登陣營核心人物,卻一直吃閉門羹。 而美國總統大選,川普選情告急,讓蔡英文與民進黨心急如焚。偏偏這時候,黎智英與香港蘋果又爆發「拜登兒子勾結中國」的假新聞事件被抓到了,而且是用虛構人物製造的「假新聞」。 誰製造的虛構人物及假新聞?是香港蘋果黎智英的私人助理,曾任職 CIA的Mark Simon ,這位仁兄也與臺灣政治多有牽連,他甚至早已在臺灣置產。 事情爆發後,當事人Mark Simon立馬辭職神隱,然後黎智英趕快表態與之切割,你們相信Mark Simon動用蘋果1萬元美金的資金不需要報告黎智英,來做這個假新聞,黎智英說不知情,你相信嗎? 但是一切都來不及了! 美國民主黨這邊,由「紐約時報」早幾天就已經摸透了川普、班農、郭文貴、和法輪功、《大紀元》及《新唐人》這些年來的勾結,還有利用FB製造假新聞的脈絡,以及香港蘋果、背後的台灣政治關係,順藤摸瓜,一拉一大串,終於拉出來一整串 ! 現在拜登陣營與美國媒體一致認定 : 「臺灣由蔡英文領導的民進黨政權勾搭香港蘋果、班農、郭文貴、法輪功側翼媒體一起為了替川普競選,造謠攻擊拜登 !」 這等於被認定民進黨政權企圖 "干涉" 美國內政,"操縱" 美國總統大選。 選情的大事,蔡英文當然要召開國安高層會議啦 ! 在美國政府眼裡,你中華民國不管是哪個政黨當家,都只是美國的奴才/馬前卒/棄子.......... 奴才竟敢伸手到主子家的內鬥裡去攪和,膽大包天啊 ! 孰可忍?孰不可忍 ! 拜登如今已確定當選,蔡英文心知肚明,這次踩到美國的 "底線" 了。 在川普的煽動下,蔡英文政府一天到晚都在激怒對岸,拼命踩中國大陸的忍耐底線,靠的是川普承諾當蔡英文的靠山; 可是蔡英文與民進黨 為了向川普表忠,玩火玩過了頭 ! 這下子奴才 "干涉" 到 宗主國的內政,罪證確鑿,蔡英文與民進黨政府,等著被美國開刀祭旗秋後算帳吧! 這時候召開國安高層會議?來得及嗎? 自己早已把醜話說盡了,也把蠢事做絕了, 現在想亡羊補牢? 為時已晚!!!
    1 人回報1 則回應6 年前
  • https://www.facebook.com/h2ulife/photos/a.1146679112070130/2398415716896457/?type=3&theater #奉氫站 陳正結先生--智利SIMON先生的台灣朋友 因為他每天都有喝兩瓶低氘氫水,所以他的容貌變年輕,皺紋消失,白髮也變黑。(請仔細比對兩張圖,他在1.5個月內,年輕了許多) 但,變成白人這件事,是低氘氫氣的作用。 警語: 美女們,低氘氫氣雖然可以美白,但那是在特殊控制的情況之下。請不要胡亂嘗試,否則變成斑馬,我不負責。亂吸製氫機的氫氣,變成長腫瘤的斑馬,我也概不負責。 另:低氘氫水雖然可以使陳先生變年輕,但是陳先生變年輕的原因可能還有許多,請不要亂買市面上的假氫水來喝,也有可能瞬間老十歲,我也不會負責。 以上是關於低氘氫氣的趣談。請不要亂吸由製氫機所產生的氫氣,很容易長腫瘤的。 https://blog.xuite.net/hworker77086600/twblog/584479957 為何不能呼吸來自於製氫機的氫氣。(frozen)
    1 人回報1 則回應8 年前
  • SIMON MALL我們的商品官網 https://shop.simon.com (記得可以使用Google翻譯成繁體中 文哦) 以B2C模式的電商模式目前剛入駐台 湾市场 是透過國際平台去招攬曝光引流進單 有消費者下單我們商家才需要出貨 免 去屯貨的風險 以高效、快速、簡便的方式經營電商 這邊有新聞的報導: 1.https://enn.tw/554207/ 好的 那我就簡單跟妳介紹一下AI 智能引流訂單的基本內容(我們的商家 系統也都可以看到各大平台的引流數 據喔) 1.官網都有提供貨源商品供我們商家 上架販售 2.系統都由AI引流進單曝光客源所以 我們不需要自行推銷 3.經營我們的電商系統是不用囤貨的 消費者付款下單之后我們商家才有需 要向雲端倉庫申請發貨 新聞的部分看完之後有興趣想經營電 商這塊副業 可以先加我們官方客 服的好友喔 還有喔雖然我們平台不需要囤貨也 不需要會費之類的費用 但你店鋪內的商品如果有消費者下 單你是需要自己向雲端倉庫申請發 貨的喔這個我都要先說 畢竟網拍就是這樣做的但選擇我們 平台的好處就是 消費者已經確定付款了我們商家才 會收到成立的訂單 所以不會有棄單的風險也不會有囤 貨的風險 基本上可以說是空手套白狼啦 接下來可以從待稽核區查看有沒有訂 單 有的話跟我說我接著教你下一 步~ 因為平台是以美金匯率為基準兩間 匯率不同 我是都會輪流使用 或妳自己本來就有的話也可以用妳 習慣的 我不是要妳玩虛擬貨幣哦 不要 碰那個 只是剛好需要用電子錢包換匯而已
    1 人回報1 則回應2 年前
  • https://www.the-scientist.com/news-opinion/lab-made-coronavirus-triggers-debate-34502 美國科學家雜誌(the scientist magazine)早在2015年已經報道,新形冠狀病毒的研發過程及製造!有文獻記載! Ralph Baric 一名美國北卡羅來納州大學有2015年11月9日刊登他們團隊,製做一種擁有SCH014表面蛋白質冠狀病毒的研究。 病毒2015年已經製造出來。從一種來自中國找到的蝙蝠身上的病毒培植,用導致老鼠感染Sars的冠狀病毒做骨幹。能夠構成嚴重上呼吸部及肺部感染。 (誰說造謠的,請找美國科學家雜誌去) the-scientist.com Lab-Made Coronavirus Triggers Debate The creation of a chimeric SARS-like virus has scientists discussing the risks of gain-of-function research. Jef Akst Nov 16, 2015 Ralph Baric, an infectious-disease researcher at the University of North Carolina at Chapel Hill, last week (November 9) published a study on his team’s efforts to engineer a virus with the surface protein of the SHC014 coronavirus, found in horseshoe bats in China, and the backbone of one that causes human-like severe acute respiratory syndrome (SARS) in mice. The hybrid virus could infect human airway cells and caused disease in mice, according to the team’s results, which were published in Nature Medicine. The results demonstrate the ability of the SHC014 surface protein to bind and infect human cells, validating concerns that this virus—or other coronaviruses found in bat species—may be capable of making the leap to people without first evolving in an intermediate host, Nature reported. They also reignite a debate about whether that information justifies the risk of such work, known as gain-of-function research. “If the [new] virus escaped, nobody could predict the trajectory,” Simon Wain-Hobson, a virologist at the Pasteur Institute in Paris, told Nature. In October 2013, the US government put a stop to all federal funding for gain-of-function studies, with particular concern rising about influenza, SARS, and Middle East respiratory syndrome (MERS). “NIH [National Institutes of Health] has funded such studies because they help define the fundamental nature of human-pathogen interactions, enable the assessment of the pandemic potential of emerging infectious agents, and inform public health and preparedness efforts,” NIH Director Francis Collins said in a statement at the time. “These studies, however, also entail biosafety and biosecurity risks, which need to be understood better.” Baric’s study on the SHC014-chimeric coronavirus began before the moratorium was announced, and the NIH allowed it to proceed during a review process, which eventually led to the conclusion that the work did not fall under the new restrictions, Baric told Nature. But some researchers, like Wain-Hobson, disagree with that decision. The debate comes down to how informative the results are. “The only impact of this work is the creation, in a lab, of a new, non-natural risk,” Richard Ebright, a molecular biologist and biodefence expert at Rutgers University, told Nature. But Baric and others argued the study’s importance. “[The results] move this virus from a candidate emerging pathogen to a clear and present danger,” Peter Daszak, president of the EcoHealth Alliance, which samples viruses from animals and people in emerging-diseases hotspots across the globe, told Nature. https://www.the-scientist.com/news-opinion/lab-made-coronavirus-triggers-debate-34502 以下是中文譯本(翻譯自 google translate app) 實驗室製造的冠狀病毒引發辯論 嵌合型SARS病毒的產生使科學家們討論了獲得功能研究的風險。 傑夫·阿克斯特 2015年11月16日 北卡羅來納大學教堂山分校的傳染病研究人員拉爾夫·巴里克(Ralph Baric)上週(11月9日)發表了一項研究,研究了他的研究小組利用在中國的馬蹄蝠中發現的具有SHC014冠狀病毒表面蛋白的病毒工程化病毒的努力。 以及引起小鼠類似人的嚴重急性呼吸系統綜合症(SARS)的骨架。 研究小組的結果發表在《自然醫學》雜誌上,該雜種病毒可能感染人的氣道細胞並引起小鼠疾病。 結果表明,SHC014表面蛋白具有結合和感染人類細胞的能力,這證實了人們對該病毒(或蝙蝠物種中發現的其他冠狀病毒)能否在不首先進化為中間宿主的情況下向人飛躍的擔憂。 他們還引發了關於該信息是否可證明進行此類工作的風險的辯論,稱為功能獲得研究。 巴黎巴斯德研究所的病毒學家西蒙·韋恩·霍布森(Simon Wain-Hobson)告訴《自然》雜誌:“如果[新]病毒逃脫了,那麼誰也無法預測這一軌跡。” 2013年10月,美國政府停止了所有用於功能獲得研究的聯邦資金,尤其是對流感,SARS和中東呼吸綜合徵(MERS)的關注日益增加。 美國國立衛生研究院主任弗朗西斯·柯林斯說:“美國國立衛生研究院(NIH)為此類研究提供了資助,因為它們有助於確定人與病原體相互作用的基本性質,能夠評估新興傳染病的大流行潛力,並為公共衛生和備災工作提供信息。” 當時在一份聲明中說。 “但是,這些研究還涉及生物安全和生物安全風險,需要更好地理解。” Baric告訴《自然》,Baric對SHC014嵌合冠狀病毒的研究在宣布暫停宣布之前就開始了,NIH允許其在審查過程中進行,最終得出結論認為該工作不屬於新的限制。 但是,一些研究人員,例如Wain-Hobson,不同意這一決定。 爭論歸結為結果如何豐富。 羅格斯大學分子生物學家兼生物防禦專家理查德·埃布賴特(Richard Ebright)對自然界說:“這項工作的唯一影響是在實驗室中創造了一種新的非自然風險。” 但巴里奇(Baric)和其他人則認為這項研究很重要。 “(結果)將這種病毒從候選的新興病原體轉移到了明顯的當前危險中,” EcoHealth Alliance總裁彼得·達薩克(Peter Daszak)告訴《自然》雜誌,該聯盟從全球新興疾病熱點地區的動物和人類中採集病毒。
    3 人回報1 則回應6 年前
  • <<專家重新審視與分析數據後 呼籲立即停止孕婦,哺乳婦女接種mRNA新冠疫苗>> https://vocus.cc/article/61834331fd89780001d63523 今年 Shimabukuro 發表關於孕婦接種COVID mRNA疫苗研究,支持孕期婦女接種新冠mRNA疫苗,持續引起許多專家的批評。 首先, 是文中舉出的827例接種mRNA疫苗的懷孕婦女中, 有700例在第三孕期才接種第一劑。妊娠20週以前發生的自然流產有104例,本身就佔了非第三孕期接種第一劑人數127人的很大比例。 在比利時專家指出分析方式與數據的謬誤之後, 作者也在上個月提出了修正, 但還是沒有改變原始的研究結論, 顯得整個研究的數據和結論不一致。 重新分析了美國疾病控制與預防中心 (CDC) 研究人員進行的一項研究後,一項同行審議的研究呼籲“立即停用針對孕婦、哺乳期婦女、育齡婦女及兒童的 mRNA COVID 疫苗”。 令人震驚的研究揭示了懷孕接種 mRNA 疫苗的驚人結果: 至少 81.9% (≥ 104/127) 在妊娠 20 週前接種 mRNA疫苗後發生自然流產,其中92.3%的流產 (96/104) 發生在妊娠 13 週前。 -Shimabukuro 等人的結論遭到質疑, 並且還有許多安全性未知。 -mRNA奈米粒子與Spike protein棘蛋白的傳播? -棘蛋白是否會從母乳中分泌? -Syncytin-1 胞合素 對細胞融合與胎盤發育至關重要, 然而Pfizer與Moderna所提供的在嚙齒動物上的研究卻無法反映出對人是否安全, 因為只有靈長類動物如恆河猴身上有與人體相似的Syn-1, Syn-2蛋白。 -在 Comirnaty(輝瑞/BioNTech mRNA)提交給食品和藥物管理局 (FDA)的疫苗包裝說明仿單,製造商聲明尚未評估男性生育能力的潛在損害。 Shimabukuro 等人依照粗糙的分析方式, 表明在懷孕婦女身上接種mRNA疫苗無安全性警示。(卻無法解釋第一孕期及第二孕期, 在20週前的高自然流產比例) 奧克蘭大學流行病學和生物統計學系高級講師 Simon Thornley 博士和紐西蘭的另一位研究員 Aleisha Brock 博士表示:在無法確立令人信服的長期安全性以及完成追蹤在胎兒期暴露的長期安全性數據以前, 不應給予孕期, 哺乳婦女, 以及孩童, 育齡婦女接種COVID mRNA疫苗。 在未完全瞭解安全性數據以前冒然給予孕期婦女新型藥物的風險和代價, 如曾在50 年代末和 60 年代初用來預防懷孕期間噁心的藥物thalidomide沙利竇邁。最終導致數千名兒童嚴重出生缺陷,其中包括數十名出生時沒有四肢的兒童。 我們是否能夠承擔這未知的風險? 詳全文:https://vocus.cc/article/61834331fd89780001d63523
    1 人回報1 則回應5 年前
  • Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions. June 30, 202110:11 AM CSTLast Updated 2 months ago Healthcare & Pharmaceuticals U.S. Commerce chief says Taiwan's TSMC asked for help getting COVID vaccines Reuters 3 minute read U.S. Secretary of Commerce Gina Raimondo takes a question during a press briefing at the White House in Washington, U.S., April 7, 2021. REUTERS/Kevin Lamarque/File Photo The logo of Taiwan Semiconductor Manufacturing Co (TSMC) is pictured at its headquarters, in Hsinchu, Taiwan, Jan. 19, 2021. REUTERS/Ann Wang/File Photo U.S. Secretary of Commerce Gina Raimondo takes a question during a press briefing at the White House in Washington, U.S., April 7, 2021. REUTERS/Kevin Lamarque/File Photo 1/2 The logo of Taiwan Semiconductor Manufacturing Co (TSMC) is pictured at its headquarters, in Hsinchu, Taiwan, Jan. 19, 2021. REUTERS/Ann Wang/File Photo WASHINGTON, June 29 (Reuters) - U.S. Commerce Secretary Gina Raimondo on Monday said she had spoken with the chief executive of Taiwan Semiconductor Manufacturing Co Ltd (2330.TW) (TSMC) and that he had asked for help getting access to COVID-19 vaccines. Raimondo told Reuters in an interview "he asked for help in that regard, he has spoken to high level officials in the White House. We have responded and we definitely want to be a good partner and I do think it's helping." Taiwan said two weeks ago it will allow officials from Taiwan's Foxconn and TSMC to negotiate on its behalf for COVID-19 vaccines. read more Mid-June the United States shipped 2.5 million COVID-19 vaccine doses to Taiwan, more than tripling Washington's previous allocation of shots for the island. read more TSMC said in a statement to Reuters that they believed "getting vaccines for Taiwan would help to protect the communities and ensure normal operations." Taiwan has been trying to speed up the arrival of the millions of vaccines it has on order as it deals with a rise in domestic cases, although infections remain comparatively low. The request from TSMC, the world's biggest manufacturer of semiconductors on contract, coincides with a global chip shortage that has slowed production of manufacturers around the world, including in the U.S. auto industry where it is forecast the crisis will hit the production of 3.9 million vehicles. Raimondo has a key role in resolving the crisis for U.S. companies. Although there has been no major impact so far on chip production in Taiwan since domestic cases began rising in the middle of May, some U.S. auto executives have told Reuters privately earlier this month they were concerned COVID-19 in Taiwan could impact the flow of semiconductors to U.S. factories. Reporting by David Shepardson in Washington; Additional reporting by Ben Blanchard in Taipei; Editing by Simon Cameron-Moore Our Standards: The Thomson Reuters Trust Principles. More from Reuters Credit Suisse to U.S. staff: get shot, or go home Credit Suisse to U.S. staff: get shot, or go home Credit Suisse to U.S. staff: get shot, or go home German business morale dips on new health worries German business morale dips on new health worries Xiaomi sees revenue surge, eyes EV-market debut Xiaomi sees revenue surge, eyes EV-market debut Toshiba reviewing new strategic ideas - sources Toshiba reviewing new strategic ideas - sources J&J says booster shot vastly increases antibdody J&J says booster shot vastly increases antibdody Qantas aims for international travel in December Qantas aims for international travel in December Air NZ suspends outlook as borders stay shut Air NZ suspends outlook as borders stay shut Japan suspends 1.6 mln doses of Moderna shot Japan suspends 1.6 mln doses of Moderna shot Shakes off menu at UK McDonald's as milk runs dry Shakes off menu at UK McDonald's as milk runs dry Legal Lookahead: Purdue Pharma makes final push to exit bankruptcy Legal Lookahead: Purdue Pharma makes final push to... Read Next United States Illinois Governor to order statewide mask mandate and order masks and vaccines for schools - media 7:55 PM CST Europe EU says COVID boosters may have higher legal risks without EMA approval 7:34 PM CST World Qatar offering COVID vaccines to Afghanistan evacuees yet to transit 7:29 PM CST Americas Brazil's Eurofarma to make Pfizer COVID-19 shots in Latin America 7:10 PM CST Sign up for our newsletter Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox. Healthcare & Pharmaceuticals Healthcare & Pharmaceuticals · 8:04 PM CST Illinois governor to announce mask mandate, order vaccines for schools - reports Illinois Governor J.B. Pritzker is expected to announce a new COVID-19 policy for the state on Thursday, requiring eligible students and school staffers to be vaccinated and to wear masks in schools and colleges, the Chicago Tribune and other media reported. Healthcare & Pharmaceuticals EU says COVID boosters may have higher legal risks without EMA approval 7:34 PM CST Healthcare & Pharmaceuticals Japan suspends 1.6 mln doses of Moderna shot after contamination reports 8:05 PM CST Healthcare & Pharmaceuticals Sydney hospitals erect emergency tents as COVID-19 cases hit record 12:32 PM CST Healthcare & Pharmaceuticals New Zealand's Ardern says lockdown working to limit Delta spread 3:10 PM CST Latest Home Media Videos Pictures Graphics Browse World Business Legal Markets Breakingviews Technology Investigations Lifestyle About Reuters About Reuters Careers Reuters News Agency Brand Attribution Guidelines Reuters Leadership Reuters Fact Check Reuters Diversity Report Stay Informed Download the App Newsletters Information you can trust Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Follow Us Thomson Reuters Products Westlaw Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. Onesource The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. Checkpoint The industry leader for online information for tax, accounting and finance professionals. Refinitiv Products Eikon Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface. Refinitiv Data Platform Access to real-time, reference, and non-real time data in the cloud to power your enterprise. World-Check Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. Advertise With Us Advertising Guidelines Cookies Terms of Use Privacy Corrections Site Feedback All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2021 Reuters. All rights reserved
    4 人回報1 則回應5 年前
  • Adam Rogas – CEO and Co-Founder of NS8 by IdeaMensch · Nov 30, 2016 287Share Tweet 66Share Adam-e1480959343307 Find a problem you think you can solve and really focus on it. Resist the urge to move from that problem until you have demonstrated by positive user feedback and growth that you have actually solved it. Adam Rogas is the CEO and Co-Founder of NS8. With over 14 years of senior development and management expertise, as well as extensive knowledge in the fields of online fraud and spam filtering, Adam brings a tremendous amount to NS8. He was a founder of LoadMail and has worked as a trusted advisor to Postini, London Board of Tourism, Vivendi Universal, and Napster. In each case, Adam has helped implement big data, email, spam and virus filtering, and data security solutions. Mr. Rogas has architected extremely large-scale spam and virus filtering platforms, dealing with well over 100,000 messages per hour. He has also played a central role in the architecture of numerous large scale analysts solutions. Adam brings his love for safe, effective communication and startup ventures to NS8. He is married and also calls Las Vegas, Nevada home. Where did the idea for NS8 come from? My partners and I have run some significant and highly transactional websites and services prior to NS8. We understood that the common threads of fraud, abuse and poor user experience affected each of them in some way, shape, or form. Knowing this, we felt there had to be a better way to protect these types of sites and services, from being abused, regardless of their size. We also knew that any solution we created had to be easy to deploy, manage, and understand. What does your typical day look like and how do you make it productive? In an early stage company you are wearing lots of hats. I work a ton of hours. So, the key for me, is to keep my thoughts organized. I usually divide my day up into 3 or 4 segments and then identify what I think I can accomplish in each one of them. Once I do this, I make a list for each segment. This gives me a semblance of structure to my day that helps me get my mind right for the tasks I have to tackle. It also helps me walk away and not overthink the ones I have already completed. How do you bring ideas to life? I usually start with an idea or something that would really matter to a specifc group of people and then I start asking questions. I will then usually build some simple example, or take steps to create what I’m trying to do, and show it to people get feedback and repeat until I reach my goal. What’s one trend that really excites you? It has gotten easier and easier to bring big ideas to life, and to compete, due to the growth of cloud services. To me, it really levels the playing field for a lot of ideas, that just 5 years ago, would have been impossible for all but the largest companies to bring to life. What is one habit of yours that makes you more productive as an entrepreneur? I try to be fairly aware of my own ADD and so I will make lists to hold myself accountable for the items on them. I also try to solve this problem in our hiring practices by surrounding myself with people that are very detail and process focused. What advice would you give your younger self? Find a problem you think you can solve and really focus on it. Resist the urge to move from that problem until you have demonstrated by positive user feedback and growth that you have actually solved it. If you do that, and continue to do it over and over again, you will be successful. Tell us something that’s true that almost nobody agrees with you on? That I am a good singer ? I don’t know that I am very persuasive here …. but I do know I can’t sing. As an entrepreneur, what is the one thing you do over and over and recommend everyone else do? I am constantly talking to our customers. I try to involve them early on, and very often in our process. This is one area I struggle with as we evolve and scale our product development processes, but it is critical to maintaining that connection as to why your customers want your product in the first place. What is one strategy that has helped you grow your business? Please explain how. Surrounding myself with supremely talented people and partners. It has been instrumental to my own growth and the growth of my businesses. What is one failure you had as an entrepreneur, and how did you overcome it? That would probably be my first company, Load Ltd. Load was a hosted application service provider before there was a term for Software As A Service (SaaS). We had a popular email product called LoadMail, that was used by a number of major companies. About 1 year into the business we chose to offer additional services above and beyond just mail and it was this decision that would prove to be our failure. As a team, we didn’t fully understand how diversifying our focus would negatively impact our effectiveness. I tell everyone who asks for advice to pick a problem you can solve and focus on solving it well. Successful entrepreneurs have one thing in common — they never give up. What is one business idea that you’re willing to give away to our readers? I like ideas that take subject knowledge and find a way to productize it. One idea I had was to do this for athletic departments in D1 schools, so they could crowdsource from their athletes, managers, and students the creation of social marketing content. They could then manage it from a centrally controllable compliance system. Or Plastics !! Invest in Plastics (god I’m old) What is the best $100 you recently spent? What and why? Money spent on experiences, dinner with my wife or friends, or money that helps someone. Recently, since we are living across the country from each other, it would be dinner with my wife the last time I was at home in Las Vegas. What is one piece of software or a web service that helps you be productive? How do you use it? Slack. It helps our entire team communicate. What is the one book that you recommend our community should read and why? “Start With Why” by Simon Sinek. It helps you think about what you are building in a way that really focuses on how it will be consumed by those whom you are selling it to. What is your favorite quote? “Success consists of going from failure to failure without loss of enthusiasm.” -Winston Churchill Tell us about one friend or acquaintance of yours who we should interview on IdeaMensch. Who are they, what are they doing and what’s their email address? I actually have two Nick Jones, Nick and I started what was our first real company together Load Ltd along with my current business partner Paul Korol. Nick’s is currently working on a great project focused on personal and affinity based content creation called JRNL.com, they have recently been through boom Startup a SaaS focused startup accelerator in Salt Lake City and have just completed a seed round of funding. John Njoku, John is working on a great project RentHub.com, which is at the intersection of Multifamily Residential Realestate and Big Data Analytics. RentHub has some huge clients such as StarWood capital and The Lefrak Organization and has recently completed the Elmspring accelerator based in Chicago. Contact : https://www.ns8.com/ LinkedIn: https://www.linkedin.com/company/ns8 Facebook: https://www.facebook.com/ns8inc Twitter: @ns8inc 287Share Tweet 66Share Filed Under: Interviews, Software, Technology Tagged With: Herndon, Virginia https://ideamensch.com/adam-rogas/
    1 人回報1 則回應9 年前
  • 評論 媒體 Lin bay 好油》由毒物科醫師示範如何玩殘農業和專業 提供新的無抗藥性的農藥給農民使用,反而能有效減少用藥,有多種不同作用機制的農藥輪替使用,更是減少用藥的最好方法。農業主管機關基於自己的職責與專業判斷來建議農藥殘留標準,食藥署依照飲食資料及科學證據來訂立農藥殘留標準並公佈,這些都來就是他們的職責。但某些媒體卻選擇使用惡意操作的角度,刻意選擇訪問和農業還有食品安全沾不上關係的毒物科專家,講一些沒有任何證據支持的論點。 作者: Lin Bay 好油 | 2018-05-25 12:31 Lin bay 好油 前幾天媒體做了個新聞,斗大標題寫著:「茶樹農藥鬆綁 第一泡別喝了」。既然農藥延伸允許使用,為什麼新聞會用這樣的標題? 報導中提到:林口長庚臨床毒物中心主任顏宗海表示,致腫瘤等級C級,是指對部分動物有風險,但對人體還沒有相關致癌的證據。而賽派芬因為只有日本使用,毒理學的相關資訊很少,對人體有何影響了解有限。因此建議民眾泡茶時,為避免農藥殘留,第一泡建議還是不要喝。 第一泡茶真的不適合喝嗎?(本報資料照) 看起來是顏宗海的建議,但毒物中心主任具備食安專業嗎?在毒物科醫師眼中,看到什麼都是毒,就算食品安全明明不是他的專業,只要記者詢問,都能侃侃而談,醫師應該要講求科學證據,但講出這種話很令人懷疑他們的專業,是說,反正講話也不用負責,講得越扯,就越能建立自己的公信力,而長庚的人也不是這樣第一次這樣搞,之前長庚臨床毒物科實驗室的林中英博士還說,因為竹筍殼會裂,蟲會跑進去,所以農民會用農藥,因為有草,農民會用除草劑。事實上竹筍的用藥非常少,藥殘過量的比例也非常的低,竹筍園因為竹林遮蔭以及地面乾枯的竹葉覆蓋,沒什麼農民在用除草劑,明明不了解農業的生產狀況也可以在鏡頭前臉不紅氣不喘地鬼扯,這就是毒物科醫師訓練的專業嗎? 第一泡茶真的不適合喝? 大多數的農藥屬於脂溶性的農藥,對於水的溶解度非常低,農民施用農藥時多數都需要配合乳化劑來讓農藥在水中能均勻散佈,而這次在茶葉允許使用的兩支新藥-賽安勃(Cyantraniliprole) 、賽派芬(Cyenopyrafen),稍微有點正常化學知識的醫師一看化學式就知道這兩隻藥屬於脂溶性,如果連化學式都沒看過就可以說出第一泡不適合喝的話,這種專業更令人搖頭。 賽安勃與賽派芬化學式。 賽安勃的殘留的茶葉,到底會泡出多毒的茶? 這次法規的殘留允許值是1.5ppm,姑且假設某品項茶葉的賽安勃殘留量是1.5ppm,賽安勃20度C溶於每公升水的數量是14.2毫克,也就是一般500毫升的水用10公克茶的沖泡方式,在這杯500毫升的茶中,賽安勃如果全部都溶到茶湯中,大約會有0.000015公克的量,而這樣茶湯有多毒? 首先,賽安勃在老鼠口服的半數致死量是2000mg/kg(Page 92 of The Toxicology and Biochemistry of Insecticides, Second Edition, By Simon J. Yu)。所以我們整理一下: 賽安勃 Oral LD50 in rat (半數致死量) 是 2000mg/kg,1杯500毫升的第一泡茶,茶葉中有賽安勃總量0.000015公克,在最惡劣的情況下,一個60公斤的成人大約要喝80萬杯500毫升的第一泡茶湯,才會產生50%的機率中毒死亡,要喝到中毒還真的很難。
    1 人回報1 則回應8 年前